Company Filing History:
1 out of 2 
1 out of 1,508 
7 out of 832,961 Years Active: 1983-2019
Title: A Martin Lerner: Innovator in Diagnosing and Treating Chronic Fatigue Syndrome
Introduction
A Martin Lerner is an eminent inventor based in Birmingham, MI, recognized for his significant contributions to the medical field, particularly in the study and treatment of Chronic Fatigue Syndrome (CFS). With a portfolio of eight patents to his name, Lerner has focused on innovative methods for diagnosing and alleviating the symptoms of this complex condition.
Latest Patents
Among Lerner's most notable recent patents is a groundbreaking method for diagnosing and treating patients impacted by Epstein Barr virus-based Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME/CFS). His first patent outlines a clinical and serological analysis that identifies Epstein Barr Virus Abortive Lytic Replication (EBV) as a causal agent. This is achieved through serum antibodies to EBV encoded dUTPase and EBV DNA Polymerase as molecular markers. Furthermore, he proposes a treatment using specific antiviral nucleosides to alleviate patients' conditions.
Another significant patent focuses on a method for diagnosing and alleviating chronic fatigue syndrome symptoms through the administration of antiviral agents. Clinical tests have indicated that chronic fatigue syndrome is often tied to persistent herpes virus infections, and the use of antiviral agents can lead to significant symptom reduction or even elimination during therapeutic trials.
Career Highlights
Lerner's career reflects a deep commitment to understanding and addressing chronic conditions affecting many individuals. His work via patents showcases his innovation and expertise in the medical diagnostic field. He has successfully integrated research and clinical practices to formulate effective treatment strategies, contributing to enhanced patient outcomes.
Collaborations
Throughout his career, A Martin Lerner has collaborated with notable professionals in the field, including Hilton B Levy and Ronald M Glaser. These partnerships have likely played a vital role in advancing the research and development of his patented methods, enhancing the impact of his work.
Conclusion
A Martin Lerner stands out as a pivotal figure in the realm of medical inventions, particularly regarding chronic fatigue syndrome. His patents not only demonstrate his innovative capabilities but also reflect his dedication to improving the health and well-being of those affected by this challenging condition. As research continues, Lerner's contributions will undeniably remain influential in the pursuit of effective diagnostics and treatments for chronic fatigue syndrome.